Recombinant Human SLC25A37 Protein, N-GST & C-His

Recombinant Human SLC25A37 Protein: A Versatile Antigen for Biomedical Research

Recombinant proteins have become an essential tool in biomedical research due to their ability to mimic naturally occurring proteins and their potential for therapeutic applications. One such recombinant protein that has gained significant attention in recent years is the Human SLC25A37 protein. This protein, also known as the mitochondrial solute carrier 25A37, has a crucial role in cellular metabolism and has been linked to various diseases. In this article, we will explore the structure, activity, and potential applications of recombinant Human SLC25A37 protein.

Structure of Recombinant Human SLC25A37 Protein

The Human SLC25A37 protein is a member of the mitochondrial carrier family, which is a group of proteins that transport metabolites across the mitochondrial inner membrane. It is a 34-kDa protein with six transmembrane domains and a conserved sequence motif that is characteristic of the mitochondrial carrier family. The recombinant form of this protein is produced by cloning the gene encoding it into a suitable expression vector and expressing it in a host organism, typically Escherichia coli or yeast. Recombinant Human SLC25A37 protein is then purified using various chromatography techniques to obtain a highly pure and active protein.

Activity of Recombinant Human SLC25A37 Protein

The primary function of Human SLC25A37 protein is to transport glutamate across the mitochondrial inner membrane. This transport is essential for the production of ATP, the energy currency of the cell. Additionally, this protein has been shown to interact with other mitochondrial proteins, such as the ADP/ATP translocase, to regulate mitochondrial metabolism. The recombinant form of this protein has been extensively studied, and it has been shown to retain its transport activity, making it a valuable tool for studying mitochondrial metabolism and its role in disease.

Applications of Recombinant Human SLC25A37 Protein

Recombinant Human SLC25A37 protein has a wide range of applications in biomedical research, including drug discovery, disease modeling, and protein-protein interaction studies. One of the most significant applications of this protein is in the development of therapeutics for diseases related to mitochondrial dysfunction. Mutations in the SLC25A37 gene have been linked to various disorders, including mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). By studying the activity and structure of recombinant Human SLC25A37 protein, researchers can gain insights into the molecular mechanisms underlying these diseases and develop targeted treatments.

Moreover, recombinant Human SLC25A37 protein has also been used as an antigen in immunological studies. Antibodies against this protein have been shown to be present in patients with autoimmune diseases, such as systemic lupus erythematosus, making it a potential biomarker for these conditions. Additionally, the recombinant form of this protein has been used to generate specific antibodies for use in diagnostic assays and as a tool for protein-protein interaction studies.

Conclusion

In conclusion, recombinant Human SLC25A37 protein is a versatile antigen with various applications in biomedical research. Its unique structure and activity make it an essential tool for studying mitochondrial metabolism and its role in disease. With ongoing research, this protein has the potential to lead to the development of targeted therapeutics for mitochondrial disorders and serve as a biomarker for autoimmune diseases. As the field of recombinant protein technology continues to advance, the potential applications of Human SLC25A37 protein are only expected to grow.